InVivo: Topline data announced from pivotal INSPIRE 2.0 study of Neuro-Spinal Scaffold for acute spinal cord injury.-InVivo Therapeutics

InVivo Therapeutics Holdings Corp. a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCI),announced topline results from the company's INSPIRE 2.0 tudy, which was designed to evaluate the safety and probable benefit of InVivo's investigational Neuro-Spinal Scaffold, a bioresorbable scaffold-based device in development for patients with acute SCI.